Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 3rd Annual STING & TLR-Targeting Therapies Summit Scopus BioPharma's Subsidiary - Duet Therapeutics - to Present at the 3rd Annual STING & TLR-Targeting Therapies Summit (03.22.22) FINAL
Scopus BioPharma to Present at the LD Micro Main Event Scopus BioPharma to Present at the LD Micro Main Event (10.05.21) FINAL
Scopus BioPharma to Present at MicroCap Rodeo’s Fall Harvest Best Ideas Conference Scopus BioPharma to Present at MicroCap Rodeo’s Fall Harvest Best Ideas Conference (10.01.21) FINAL
Scopus BioPharma’s Subsidiary — Duet Therapeutics — Set to Release Scientific Data During the 17th Annual Meeting of the Oligonucleotide Therapeutics Society Scopus BioPharma’s Subsidiary - Duet Therapeutics - Set to Release Scientific Data (09.28.21) FINAL
Scopus BioPharma’s Subsidiary — Duet Therapeutics — Announces Release of Preclinical Data Being Presented at 17th Annual Meeting of the Oligonucleotide Therapeutics Society Scopus BioPharma's Subsidiary — Duet Therapeutics — Announces Release of Scientific Data (09.29.21) FINAL
Scopus BioPharma to Present at the Benzinga Healthcare Small Cap Conference Scopus BioPharma's Subsidiary - Duet Therapeutics - to Present at the Benzinga Healthcare Small Cap Conference (09.23.21) FINAL